Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Giulia, Brisotto"'
Autor:
Silvio Ken Garattini, Debora Basile, Valli’ De Re, Giulia Brisotto, Gianmaria Miolo, Vincenzo Canzonieri, Giuseppe Aprile, Carla Corvaja, Silvia Buriolla, Enrico Garattini, Fabio Puglisi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundGastric cancer is a heterogeneous collection of tumors characterized by low survival rates. All-trans retinoic acid (retinoic-acid) is a clinically useful therapeutic agent belonging to the chemical family of retinoids, which consists of bo
Externí odkaz:
https://doaj.org/article/05bc3cdb6664411c936872f61ba7e927
Autor:
Daniele Boso, Martina Tognon, Matteo Curtarello, Sonia Minuzzo, Ilaria Piga, Valentina Brillo, Elisabetta Lazzarini, Jessica Carlet, Ludovica Marra, Chiara Trento, Andrea Rasola, Ionica Masgras, Leonardo Caporali, Fabio Del Ben, Giulia Brisotto, Matteo Turetta, Roberta Pastorelli, Laura Brunelli, Filippo Navaglia, Giovanni Esposito, Angela Grassi, Stefano Indraccolo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-19 (2023)
Abstract Background Genetic and metabolic heterogeneity are well-known features of cancer and tumors can be viewed as an evolving mix of subclonal populations, subjected to selection driven by microenvironmental pressures or drug treatment. In previo
Externí odkaz:
https://doaj.org/article/291e0ae6448e4b3eb631add9fd1a77cb
Autor:
Lorenzo Vinante, Angela Caroli, Alberto Revelant, Federica Bertini, Anna Giroldi, Marta Marson, Giovanni Franchin, Elena Muraro, Giulia Brisotto, Agostino Steffan, Lorena Baboci
Publikováno v:
Breast, Vol 65, Iss , Pp 49-54 (2022)
Background: and purpose: Radiation recall dermatitis is an adverse event predominantly due to systemic therapy administration after a previous radiation therapy course. Few case reports describe radiation recall dermatitis in breast cancer patients t
Externí odkaz:
https://doaj.org/article/3ca7c78b23ee4d00b2f08db5ef8c6fc2
Autor:
Valli De Re, Egesta Lopci, Giulia Brisotto, Caterina Elia, Lara Mussolin, Maurizio Mascarin, Emanuele Stefano Giovanni d’Amore, AIEOP The Hodgkin’s Lymphoma Research Network
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 31 (2023)
The primary objective of this study was to investigate the potential role of tissue osteopontin, also known as secreted phosphoprotein 1 (SPP1), as a contributing factor to an unfavorable prognosis in classical Hodgkin’s lymphoma (HL) patients who
Externí odkaz:
https://doaj.org/article/6e35fd9a18204f1d98d615d1c14a0450
Autor:
Valli De Re, Ombretta Repetto, Lara Mussolin, Giulia Brisotto, Caterina Elia, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, Maurizio Mascarin
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Currently-available therapies for newly-diagnosed pediatric and adolescent patients with Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long-term treatment-related side effects, however, so the past 20 years
Externí odkaz:
https://doaj.org/article/25b8bf36454644cabb8584bbed9308eb
Autor:
Elena Muraro, Fabio Del Ben, Matteo Turetta, Daniela Cesselli, Michela Bulfoni, Rita Zamarchi, Elisabetta Rossi, Simon Spazzapan, Riccardo Dolcetti, Agostino Steffan, Giulia Brisotto
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMetastatic breast cancer (mBC) is a heterogeneous disease with varying responses to treatments and clinical outcomes, still requiring the identification of reliable predictive biomarkers. In this context, liquid biopsy has emerged as a powe
Externí odkaz:
https://doaj.org/article/040e787fb799494f91c25f50cb0aee9a
Autor:
Giulia Brisotto, Marcella Montico, Matteo Turetta, Stefania Zanussi, Maria Rita Cozzi, Roberto Vettori, Romina Boschian Boschin, Lorenzo Vinante, Fabio Matrone, Alberto Revelant, Elisa Palazzari, Roberto Innocente, Giuseppe Fanetti, Lorenzo Gerratana, Mattia Garutti, Camilla Lisanti, Silvia Bolzonello, Milena Sabrina Nicoloso, Agostino Steffan, Elena Muraro
Publikováno v:
Viruses, Vol 15, Iss 6, p 1276 (2023)
Cellular and humoral immunity are both required for SARS-CoV-2 infection recovery and vaccine efficacy. The factors affecting mRNA vaccination-induced immune responses, in healthy and fragile subjects, are still under investigation. Thus, we monitore
Externí odkaz:
https://doaj.org/article/ab496ba7588e440cb573daffd0d671a9
Autor:
Eleonora Grisard, Michela Coan, Laura Cesaratto, Ilenia Rigo, Luigi Zandonà, Alice Paulitti, Eva Andreuzzi, Gian Luca Rampioni Vinciguerra, Evelina Poletto, Fabio Del Ben, Giulia Brisotto, Eva Biscontin, Matteo Turetta, Erik Dassi, Alex Mirnezami, Vincenzo Canzonieri, Andrea Vecchione, Gustavo Baldassarre, Maurizio Mongiat, Riccardo Spizzo, Milena S. Nicoloso
Publikováno v:
EBioMedicine, Vol 46, Iss , Pp 79-93 (2019)
Background: Metastatic colorectal cancer (CRC) remains a deadly disease. Identifying locally advanced CRC patients with high risk of developing metastasis and improving outcome of metastatic CRC patients require discovering master regulators of metas
Externí odkaz:
https://doaj.org/article/65819285dbeb46fc8b4f3deca1813892
Autor:
Muraro, Giulia Brisotto, Marcella Montico, Matteo Turetta, Stefania Zanussi, Maria Rita Cozzi, Roberto Vettori, Romina Boschian Boschin, Lorenzo Vinante, Fabio Matrone, Alberto Revelant, Elisa Palazzari, Roberto Innocente, Giuseppe Fanetti, Lorenzo Gerratana, Mattia Garutti, Camilla Lisanti, Silvia Bolzonello, Milena Sabrina Nicoloso, Agostino Steffan, Elena
Publikováno v:
Viruses; Volume 15; Issue 6; Pages: 1276
Cellular and humoral immunity are both required for SARS-CoV-2 infection recovery and vaccine efficacy. The factors affecting mRNA vaccination-induced immune responses, in healthy and fragile subjects, are still under investigation. Thus, we monitore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::db5f37a849d6c8d7f05d102ef2953df6
Autor:
Valli De Re, Mariangela De Zorzi, Laura Caggiari, Ombretta Repetto, Giulia Brisotto, Raffaela Magris, Stefania Zanussi, Agostino Steffan, Renato Cannizzaro
Publikováno v:
Microorganisms, Vol 9, Iss 1, p 126 (2021)
Background: Pepsinogen (PG) II (PGII) is a serological marker used to estimate the risk of gastric cancer but how PGII expression is regulated is largely unknown. It has been suggested that PGII expression, from the PGC (Progastricsin) gene, is regul
Externí odkaz:
https://doaj.org/article/1a9c262b0d694b61be0cbee96004f67f